Bacterial-induced infectious diseases have always caused
an unavoidable
problem and lead to an increasing threat to human health. Hence, there
is an urgent need for effective antibacterial strategies to treat
infectious diseases. Current methods are often ineffective and require
large amounts of hydrogen peroxide (H2O2), with
harmful effects on normal healthy tissue. Chemodynamic therapy (CDT)
provides an ideal infection microenvironment (IME)-activated paradigm
to tackle bacterial-related diseases. To take full advantage of the
specificity of IME and enhanced CDT for wounds with bacterial infection,
we have designed an intelligent antibacterial system that exploits
nanocatalytic ZIF-67@Ag2O2 nanosheets. In this
system, silver peroxide nanoparticles (Ag2O2 NPs) were grown on ultrathin zeolitic imidazolate framework-67 (ZIF-67)
nanosheets by in situ oxidation, and then, ZIF-67@Ag2O2 nanosheets with the ability to self-generate H2O2 were triggered by the mildly acidic environment of
IME. Lamellar ZIF-67 nanosheets were shown to rapidly degrade and
release Co2+, allowing the conversion of less reactive
H2O2 into the highly toxic reactive oxygen species
hydroxyl radicals (•OH) for enhanced CDT antibacterial
properties. In vivo results revealed that the ZIF-67@Ag2O2 nanosheet system exhibits excellent antibacterial
performance against both Gram-positive (Staphylococcus
aureus) and Gram-negative (Escherichia
coli) bacteria. The proposed hybrid strategy demonstrates
a promising therapeutic strategy to enable antibacterial agents with
IME-responsive nanocatalytic activity to circumvent antibiotic resistance
against bacterial infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.